Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Tissue Microarray Market Be Worth By 2029?

There has been a robust expansion in the market size of tissue microarray in the past few years. The market, valued at $12.05 billion in 2024, is expected to increase to $13.11 billion by 2025, with a compound annual growth rate (CAGR) of 8.8%. The significant growth during the historic period can be linked to advancements such as precision medicine, drug discovery and development, efficient analysis, and increasing cases of chronic illnesses, along with initiatives in biobanking.

The market for tissue microarray is predicted to undergo quick expansion in the upcoming years. It’s projected to rise to $20.85 billion in 2029 with a compound annual growth rate (CAGR) of 12.3%. Factors such as the introduction of digital pathology, broadened applications, expansion of the biopharmaceutical industry, regulatory backing and standards, and the integration of AI and machine learning contribute to this growth in the forecast period. Major trends expected to shape the market during this period include progress in imaging technologies, the creation of 3D tissue microarrays, high-content screening, initiatives for standardization, and the incorporation of single-cell analysis.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Which Key Factors Are Fueling Growth In The Tissue Microarray Market?

The escalating count of cancer incidents is anticipated to fuel the expansion of the tissue microarray market in the future. Cancer refers to a class of diseases that can emerge in any body’s organ or tissue when abnormal cells multiply without control, overstep their normal limits, and either metastasize to other organs or infiltrate adjacent parts of the body. Tissue arrays play a critical role in oncology by scrutinizing the expression of cancer-related biomarkers in diverse tumor specimens. As an example, the data released by the Macmillan Cancer Support, a cancer charity based in the UK, showed that the population of people battling cancer reached 3 million in 2022 in June. This figure is forecasted to surge to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Hence, the increasing count of cancer incidents is steering the expansion of the tissue microarray market.

Which Segmentation Factors Are Critical In The Tissue Microarray Market Analysis?

The tissue microarraymarket covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

What Are The Dominant Trends Currently Seen In The Tissue Microarray Market?

The rising trend of strategic alliances is significantly impacting the tissue microarray market. Many leading firms in this market are entering into partnerships to foster collaborative development of tissue microarray technologies. For example, in November 2022, The Cureline Group, a firm based in the US that provides translational and precision medicine CRO services, including HBS biobanking and laboratory services, formed a partnership with Cellecta Inc., also a US-based firm that specializes in RNAi and CRISPR screening products and services. This partnership led to the launch of Tissue 2 Target Services, an innovative strategic collaboration that amalgamates both companies’ key strengths in cellular and tissue molecular analysis and human biospecimen management, thereby offering facilities for pre-clinical and translational research that specialize in gene target and biomarker discovery services and facilitate more streamlined workflows. Additionally, in September 2022, Ultivue Inc., a US-based biotech firm that offers reagent-based solutions for maximizing the biological information obtainable from tissue and cell samples, entered into a collaboration with the Switzerland-based Translational Research Unit (TRU) platform ngTMA from the University of Bern, known for their innovative tissue microarray construction workflows. The goal of this collaboration is to enhance mIF assays and to implement novel TMA technologies to enable more effective spatial analysis in scientific research, while also improving the quality of TMAs used in both clinical and translational research.

Which Players Are Shaping The Competitive Landscape Of The Tissue Microarray Market?

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Tissue Microarray Market?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Browse Through More Reports Similar to the Global Tissue Microarray Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Computer Peripheral Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computer-peripheral-equipment-global-market-report

Computed Tomography Ct Scanners Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model